Blood Advances · 2021 · 14 citations · 22 references
Life SciencesCell BiologyMolecular BiologyCell SignalingOncogenesSignal TransductionCalcium-binding ProteinsCell Signaling NetworksMyeloproliferative NeoplasmsOncogenic Signaling PathwaysCalr MutationsJak-stat Signaling PathwayJak2 MutationsMpl MutationsThrombopoietin Receptor SignalingZinc Binding ProteinsZinc Chelation TherapyZinc Interactions
Calreticulin (CALR) is mutated in the majority of JAK2/MPL-unmutated myeloproliferative neoplasms (MPNs). Mutant CALR (CALRdel52) exerts its effect by binding to the thrombopoietin receptor MPL to cause constitutive activation of JAK-STAT signaling. In this study, we performed an extensive mutagenesis screen of the CALR globular N-domain and revealed 2 motifs critical for CALRdel52 oncogenic activity: (1) the glycan-binding lectin motif and (2) the zinc-binding domain. Further analysis demonstrated that the zinc-binding domain was essential for formation of CALRdel52 multimers, which was a co-requisite for MPL binding. CALRdel52 variants incapable of binding zinc were unable to homomultimerize, form CALRdel52-MPL heteromeric complexes, or stimulate JAK-STAT signaling. Finally, treatment with zinc chelation disrupted CALRdel52-MPL complexes in hematopoietic cells in conjunction with preferential eradication of cells expressing CALRdel52 relative to cells expressing other MPN oncogenes. In addition, zinc chelators exhibited a therapeutic effect in preferentially impairing growth of CALRdel52-mutant erythroblasts relative to unmutated erythroblasts in primary cultures of MPN patients. Together, our data implicate zinc as an essential cofactor for CALRdel52 oncogenic activity by enabling CALRdel52 multimerization and interaction with MPL, and suggests that perturbation of intracellular zinc levels may represent a new approach to abrogate the oncogenic activity of CALRdel52 in the treatment of MPNs.
22
Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
Thorsten Klampfl, Heinz Gisslinger, Ashot S. Harutyunyan et al. · New England Journal of Medicine · 2013 · 2K citations · Full text
Medicine, Genetics, Hematology +14
Calreticulin: one protein, one gene, many functions
Marek Michalak, Elaine F. Corbett, Nasrin Mesaeli et al. · Biochemical Journal · 1999 · 720 citations · Full text
Calreticulin: one protein, one gene, many functions
Marek Michalak, Elaine F. Corbett, Nasrin Mesaeli et al. · Biochemical Journal · 1999 · 607 citations
Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants
Ilyas Chachoua, C. Pecquet, Mira El-Khoury et al. · Blood · 2015 · 336 citations · Full text